- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02825667
Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle
Randomized Clinical Study on the Effectiveness of the Myofascial Therapy in the Treatment of the Hemophilic Arthropathy of Ankle
Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition.
At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients diagnosed with hemophilia A and B
- Adults patients
- Patients with hemophilic arthropathy of ankle diagnosed
- Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX.
Exclusion Criteria:
- Patients without ambulation
- Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease)
- Patients who have developed antibodies to FVIII / FIX (inhibitors)
- Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical
- Patients that have not signed the informed consent document.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Experimental group
Patients included in this group will receive treatment over a period of three weeks, receiving 3 physiotherapy sessions lasting approximately 30 minutes each. The treatment program includes 8 maneuvers that must be administered bilaterally: maneuver longitudinal sliding on the fascial surface plant, maneuver induction of the plantar fascia, maneuver longitudinal surface sliding on the anterolateral compartment of the leg, induction maneuver ankle anterior compartment, maneuver pressure and sliding on the posterior region of the leg, technical release of the popliteal fascia, maneuver induction sural triceps, and lower extremity telescopic technique. |
Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy
|
NO_INTERVENTION: Control group
Patients included in this group will not receive any physiotherapy treatment.
However, will be evaluated under the same conditions that patients in the experimental group (pretreatment evaluation, post-treatment and follow-up).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline bleeding frequency after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Evaluation of the frequency of muscle and joint bleeds through registration.
The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study.
|
Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from baseline joint pain of ankle after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from joint pain of ankle during treatment and follow-up period at 5 months.
The perception of ankle pain will be measured using visual analog scale (scale 0-10).
|
Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from baseline joint function after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from joint health during treatment and follow-up period at 5 months.
Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
|
Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from baseline range of motion after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Change from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia |
Screening visit, within the first seven days after treatment and after five months follow-up visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Height
Time Frame: Screening visit
|
Height of patients
|
Screening visit
|
Age
Time Frame: Screening visit
|
Age of patients
|
Screening visit
|
Weight
Time Frame: Screening visit
|
Weight of patients included in the study
|
Screening visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AnHe-Fascial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Haemophilia
-
Al-Azhar UniversityActive, not recruiting
-
University of ValenciaUnknown
-
Novo Nordisk A/SCompletedHaemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BFrance, United States, India, Mexico, United Kingdom, Netherlands, Sweden, Korea, Republic of, Spain, Switzerland, Serbia, Turkey, Bulgaria, Italy, Japan, Poland, South Africa, Croatia, Algeria, Australia, Bosnia and Herzegovina, ... and more
-
Novo Nordisk A/SCompletedEpidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BIndia, Morocco, South Africa, Oman
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BSpain
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Novo Nordisk A/SWithdrawnHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsSpain, Canada, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsBrazil
Clinical Trials on Physiotherapy sessions
-
University Hospital, GhentBelgium Health Care Knowledge Centre; National Institute for Health and Disability...CompletedRehabilitation | Arthroplasty, Replacement, Knee | Hip ArthrosisBelgium
-
Hospital Universitari de BellvitgeCompleted
-
University of Southern CaliforniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedEarly Child DevelopmentUnited States
-
Hacettepe UniversityCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Michigan State UniversityNational Cancer Institute (NCI)Completed
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
International Centre for Diarrhoeal Disease Research...Population Council; Marie Stopes International; Bangladesh Legal Aid and Services... and other collaboratorsCompletedSexual and Reproductive Health and Rights | Violence Against Women and Girls
-
University of OviedoCompletedParkinson Disease